Richard Champlin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Couriel Daniel R; Saliba Rima; de Lima Marcos; Giralt Sergio; Andersson Borje; Khouri Issa; Hosing Chitra; Ippoliti Cindy; Shpall Elizabeth J; Champlin Richard; Alousi Amin
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.
Armistead Paul M; de Lima Marcos; Pierce Sherry; Qiao Wei; Wang Xuemei; Thall Peter F; Giralt Sergio; Ravandi Farhad; Kantarjian Hagop; Champlin Richard; Estey Elihu
Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia.
Popat Uday; Saliba Rima; Thandi Rupinderjit; Hosing Chitra; Qazilbash Muzaffar; Anderlini Paolo; Shpall Elizabeth; McMannis John; Körbling Martin; Alousi Amin; Andersson Borje; Nieto Yago; Kebriaei Partow; Khouri Issa; de Lima Marcos; Weber Donna; Thomas Sheeba; Wang Michael; Jones Roy; Champlin Richard; Giralt Sergio
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Richard Champlin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Couriel Daniel R; Saliba Rima; de Lima Marcos; Giralt Sergio; Andersson Borje; Khouri Issa; Hosing Chitra; Ippoliti Cindy; Shpall Elizabeth J; Champlin Richard; Alousi Amin
A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(12):1555-62.
2009: Armistead Paul M; de Lima Marcos; Pierce Sherry; Qiao Wei; Wang Xuemei; Thall Peter F; Giralt Sergio; Ravandi Farhad; Kantarjian Hagop; Champlin Richard; Estey Elihu
Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1431-8.
2009: Popat Uday; Saliba Rima; Thandi Rupinderjit; Hosing Chitra; Qazilbash Muzaffar; Anderlini Paolo; Shpall Elizabeth; McMannis John; Körbling Martin; Alousi Amin; Andersson Borje; Nieto Yago; Kebriaei Partow; Khouri Issa; de Lima Marcos; Weber Donna; Thomas Sheeba; Wang Michael; Jones Roy; Champlin Richard; Giralt Sergio
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):718-23.
2009: De Padua Silva L; de Lima M; Kantarjian H; Faderl S; Kebriaei P; Giralt S; Davisson J; Garcia-Manero G; Champlin R; Issa J-P; Ravandi F
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome.
Bone marrow transplantation 2009;43(11):839-43.
2009: Jabbour Elias; Giralt Sergio; Kantarjian Hagop; Garcia-Manero Guillermo; Jagasia Madan; Kebriaei Partow; de Padua Leandro; Shpall Elizabeth J; Champlin Richard; de Lima Marcos
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia.
Cancer 2009;115(9):1899-905.
2009: Champlin Richard; de Lima Marcos; Kebriaei Partow; Rondon Gabriela; Fisher Tobi; Jabbour Elias; Cortés Jorge E; Kantarjian Hagop; Anderlini Paolo; Alousi Amin; Hosing Chitra; Shpall Elizabeth; Popat Uday; Qazilbash Muzaffar; Andersson Borje; Giralt Sergio
Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.
Clinical lymphoma & myeloma 2009;9 Suppl 3():S261-5.
2008: Rondón Gabriela; Saliba Rima M; Khouri Issa; Giralt Sergio; Chan Kawah; Jabbour Elias; McMannis John; Champlin Richard; Shpall Elizabeth
Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):859-66.
2008: de Lima M; McMannis J; Gee A; Komanduri K; Couriel D; Andersson B S; Hosing C; Khouri I; Jones R; Champlin R; Karandish S; Sadeghi T; Peled T; Grynspan F; Daniely Y; Nagler A; Shpall E J
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.
Bone marrow transplantation 2008;41(9):771-8.
2007: Gurkan E; Patah P A; Saliba R M; Ramos C A; Anderson B S; Champlin R; de Lima M; Lichtiger B
Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2007;40(5):461-4.
2007: Lin Edward H; Hassan Manal; Li Yanan; Zhao Hua; Nooka Ajay; Sorenson Elizabeth; Xie Keping; Champlin Richard; Wu Xifeng; Li Donghui
Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence.
Cancer 2007;110(3):534-42.
2007: Patah P A; Parmar S; McMannis J; Sadeghi T; Karandish S; Rondon G; Tarrand J; Champlin R; de Lima M; Shpall E J
Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
Bone marrow transplantation 2007;40(4):365-8.
2007: Jabbour Elias; Cortes Jorge; Kantarjian Hagop; Giralt Sergio; Andersson Borje S; Giles Francis; Shpall Elizabeth; Kebriaei Partow; Champlin Richard; de Lima Marcos
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity.
Cancer 2007;110(2):340-4.
2007: Christoforidou Anna V; Saliba Rima M; Williams Patricia; Qazilbash Muzaffar; Roden Linda; Aleman Ana; Weber Donna; Mendoza Floralyn; Podoloff Donald; Wendt Richard; Breitz Hazel; Alexanian Raymond; Champlin Richard; Giralt Sergio
Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(5):543-9.
2007: Estey Elihu; de Lima Marcos; Tibes Raoul; Pierce Sherry; Kantarjian Hagop; Champlin Richard; Giralt Sergio
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).
Blood 2007;109(4):1395-400.
2006: Jabbour Elias; Cortes Jorge; Kantarjian Hagop M; Giralt Sergio; Jones Dan; Jones Roy; Giles Francis; Andersson Borje S; Champlin Richard; de Lima Marcos
Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure.
Blood 2006;108(4):1421-3.
2006: Hosing Chitra; Saliba Rima M; Körbling Martin; Acholonu Sandra; McMannis John; Anderlini Paolo; Giralt Sergio; De Lima Marcos; Okoroji Grace-Julia; Couriel Daniel R; Champlin Richard; Khouri Issa F; Donato Michele L
High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2006;47(7):1290-4.
2006: Tsimberidou Apostolia-Maria; O'Brien Susan; Khouri Issa; Giles Francis J; Kantarjian Hagop M; Champlin Richard; Wen Sijin; Do Kim-Anh; Smith Susan C; Lerner Susan; Freireich Emil J; Keating Michael J
Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2343-51.
2006: Couriel Daniel R; Hosing Chitra; Saliba Rima; Shpall Elizabeth J; Anderlini Paolo; Rhodes Beverly; Smith Veronica; Khouri Issa; Giralt Sergio; de Lima Marcos; Hsu Yvonne; Ghosh Shubhra; Neumann Joyce; Andersson Borje; Qazilbash Muzzafar; Hymes Sharon; Kim Stella; Champlin Richard; Donato Michele
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.
Blood 2006;107(8):3074-80.
2006: Qazilbash Muzaffar H; Saliba Rima; De Lima Marcos; Hosing Chitra; Couriel Daniel; Aleman Ana; Roden Linda; Champlin Richard; Giralt Sergio A
Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma.
Cancer 2006;106(5):1084-9.
2006: Robinson S N; Ng J; Niu T; Yang H; McMannis J D; Karandish S; Kaur I; Fu P; Del Angel M; Messinger R; Flagge F; de Lima M; Decker W; Xing D; Champlin R; Shpall E J
Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells.
Bone marrow transplantation 2006;37(4):359-66.
2006: Couriel Daniel; Hosing Chitra; Saliba Rima; Shpall Elizabeth J; Andelini Paolo; Popat Uday; Donato Michele; Champlin Richard
Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(1 Suppl 2):37-40.
2006: Parmar S; Robinson S N; Komanduri K; St John L; Decker W; Xing D; Yang H; McMannis J; Champlin R; de Lima M; Molldrem J; Rieber A; Bonyhadi M; Berenson R; Shpall E J
Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.
Cytotherapy 2006;8(2):149-57.
2005: Qazilbash Muzaffar H; Qu Zhenhong; Hosing Chitra; Couriel Daniel; Donato Michele; Giralt Sergio; Champlin Richard
Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia.
American journal of hematology 2005;80(1):43-5.
2005: Couriel D R; Saliba R; Escalón M P; Hsu Y; Ghosh S; Ippoliti C; Hicks K; Donato M; Giralt S; Khouri I F; Hosing C; de Lima M J; Andersson B; Neumann J; Champlin R
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease.
British journal of haematology 2005;130(3):409-17.
2005: Aviner Shraga; Yao Xin; Krauthgamer Rita; Gan Yehudit; Goren-Arbel Rinat; Klein Tirza; Tabilio Antonio; McMannis John D; Champlin Richard; Martelli Massimo F; Bachar-Lustig Esther; Reisner Yair
Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation.
Human immunology 2005;66(6):644-52.
2005: Kantarjian Hagop; Talpaz Moshe; O'Brien Susan; Giles Francis; Faderl Stefan; Verstovsek Srdan; Garcia-Manero Guillermo; Shan Jianqin; Rios Mary Beth; Champlin Richard; de Lima Marcos; Cortes Jorge
Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia--comparison with historic experience.
Cancer 2005;103(10):2099-108.
2005: Kontoyiannis Dimitrios P; Lionakis Michail S; Lewis Russell E; Chamilos Georgios; Healy Mimi; Perego Cheryl; Safdar Amar; Kantarjian Hagop; Champlin Richard; Walsh Thomas J; Raad Issam I
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.
The Journal of infectious diseases 2005;191(8):1350-60.
2005: Wong Raymond; Shahjahan Munir; Wang Xuemei; Thall Peter F; De Lima Marcos; Khouri Issa; Gajewski James; Alamo Jorge; Couriel Daniel; Andersson Borje S; Donato Michelle; Hosing Chitra; Komanduri Krishna; Anderlini Paolo; Molldrem Jeffrey; Ueno Naoto T; Estey Elihu; Ippoliti Cindy; Champlin Richard; Giralt Sergio
Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):108-14.
2005: Körbling M; Robinson S; Estrov Z; Champlin R; Shpall E
Umbilical cord blood-derived cells for tissue repair.
Cytotherapy 2005;7(3):258-61.
2005: Robinson S; Niu T; de Lima M; Ng J; Yang H; McMannis J; Karandish S; Sadeghi T; Fu P; del Angel M; O'Connor S; Champlin R; Shpall E
Ex vivo expansion of umbilical cord blood.
Cytotherapy 2005;7(3):243-50.
2004: Couriel Daniel; Caldera Humberto; Champlin Richard; Komanduri Krishna
Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.
Cancer 2004;101(9):1936-46.
2004: Alexanian R; Weber D; Delasalle K; Handy B; Champlin R; Giralt S
Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma.
Bone marrow transplantation 2004;34(3):229-34.
2004: de Lima Marcos; Anagnostopoulos Athanasios; Munsell Mark; Shahjahan Munir; Ueno Naoto; Ippoliti Cindy; Andersson Borje S; Gajewski James; Couriel Daniel; Cortes Jorge; Donato Michele; Neumann Joyce; Champlin Richard; Giralt Sergio
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation.
Blood 2004;104(3):865-72.
2004: Couriel Daniel; Saliba Rima; Hicks Krystal; Ippoliti Cindy; de Lima Marcos; Hosing Chitra; Khouri Issa; Andersson Borje; Gajewski James; Donato Michele; Anderlini Paolo; Kontoyiannis Dimitrios P; Cohen Agueda; Martin Thomas; Giralt Sergio; Champlin Richard
Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.
Blood 2004;104(3):649-54.
2004: Patel Shreyaskumar R; Papadopolous Nicholas; Raymond A Kevin; Donato Michele; Seong Chu-Myong; Yasko Alan W; Lewis Valerae O; Lin Patrick P; Champlin Richard; Benjamin Robert S
A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis.
Cancer 2004;101(1):156-63.
2004: Anagnostopoulos Athanasios; Aleman Ana; Ayers Gregory; Donato Michele; Champlin Richard; Weber Donna; Alexanian Raymond; Giralt Sergio
Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.
Cancer 2004;100(12):2607-12.
2004: El-Zimaity Maha; Saliba Rima; Chan Kawah; Shahjahan Munir; Carrasco Antonio; Khorshid Ola; Caldera Humberto; Couriel Daniel; Giralt Sergio; Khouri Issa; Ippoliti Cindy; Champlin Richard; de Lima Marcos
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters.
Blood 2004;103(12):4674-80.
2004: Thomas Deborah A; Faderl Stefan; Cortes Jorge; O'Brien Susan; Giles Francis J; Kornblau Steven M; Garcia-Manero Guillermo; Keating Michael J; Andreeff Michael; Jeha Sima; Beran Miloslav; Verstovsek Srdan; Pierce Sherry; Letvak Laurie; Salvado August; Champlin Richard; Talpaz Moshe; Kantarjian Hagop
Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate.
Blood 2004;103(12):4396-407.
2004: Couriel Daniel R; Saliba Rima M; Giralt Sergio; Khouri Issa; Andersson Borje; de Lima Marcos; Hosing Chitra; Anderlini Paolo; Donato Michelle; Cleary Karen; Gajewski James; Neumann Joyce; Ippoliti Cindy; Rondon Gabriela; Cohen Agueda; Champlin Richard
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):178-85.
2004: Anagnostopoulos A; Aleman A; Yang Y; Donato M; Weber D; Champlin R; Smith T; Alexanian R; Giralt S
Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy.
Bone marrow transplantation 2004;33(6):623-8.
2003: Chatzinikolaou Ioannis; Hanna Hend; Graviss Linda; Chaiban Gassan; Perego Cheryl; Arbuckle Rebecca; Champlin Richard; Darouiche Rabih; Samonis George; Raad Issam
Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2003;24(12):961-3.
2003: Khorshid O; de Meis E; Martin T; Jones R B; Shpall E J; Nieto Y; Khouri I; Shahjahan M; Gajewski J; Giralt S; Champlin R; de Lima M
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(12):2538-40.
2003: Giralt Sergio; Bensinger William; Goodman Mark; Podoloff Donald; Eary Janet; Wendt Richard; Alexanian Raymond; Weber Donna; Maloney David; Holmberg Leona; Rajandran Joseph; Breitz Hazel; Ghalie Richard; Champlin Richard
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials.
Blood 2003;102(7):2684-91.
2003: Körbling M; Estrov Z; Champlin R
Adult stem cells and tissue repair.
Bone marrow transplantation 2003;32 Suppl 1():S23-4.
2003: Kontoyiannis Dimitrios P; Hachem Ray; Lewis Russell E; Rivero Gustavo A; Torres Harrys A; Thornby John; Champlin Richard; Kantarjian Hagop; Bodey Gerald P; Raad Issam I
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies.
Cancer 2003;98(2):292-9.
2003: Wong Raymond; Beguelin Guillermo Z; de Lima Marcos; Giralt Sergio A; Hosing Chitra; Ippoliti Cindy; Forman Arthur D; Kumar Ashok J; Champlin Richard; Couriel Daniel
Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation.
British journal of haematology 2003;122(1):128-34.
2003: Wong Raymond; de Lima Marcos; Couriel Daniel; Giralt Sergio; Hosing Chitra; Shahjahan Munir; Cheng Yee Chung; Bruton Jill; Champlin Richard; Khouri Issa
Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab.
Leukemia & lymphoma 2003;44(5):829-32.
2003: de Lima Marcos; Ravandi Farhad; Shahjahan Munir; Andersson Borje; Couriel Daniel; Donato Michele; Khouri Issa; Gajewski James; van Besien Koen; Champlin Richard; Giralt Sergio; Kantarjian Hagop
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias.
Cancer 2003;97(5):1242-7.
2003: Herne Kelly L; Talpur Rakhshandra; Breuer-McHam Joan; Champlin Richard; Duvic Madeleine
Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sézary syndrome.
Blood 2003;101(6):2132-6.
2003: Champlin Richard; Khouri Issa; Anderlini Paolo; De Lima Marcos; Hosing Chitra; McMannis John; Molldrem Jeffrey; Ueno Naoto; Giralt Sergio
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.
Oncology (Williston Park, N.Y.) 2003;17(1):94-100; discussion 103-7.
2002: Guo J Q; Lin H; Kantarjian H; Talpaz M; Champlin R; Andreeff M; Glassman A; Arlinghaus R B
Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(12):2447-53.
2002: Gajewski James L; Ippoliti Cindy; Ma Yan; Champlin Richard
Discontinuation of immunosuppression for prevention of kidney graft rejection after receiving a bone marrow transplant from the same HLA identical sibling donor.
American journal of hematology 2002;71(4):311-3.
2002: De Lima Marcos; St John Lisa S; Wieder Eric D; Lee Ming S; McMannis John; Karandish Safa; Giralt Sergio; Beran Miroslav; Couriel Daniel; Korbling Martin; Bibawi Samer; Champlin Richard; Komanduri Krishna V
Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units.
British journal of haematology 2002;119(3):773-6.
2002: Couriel D R; Beguelin G Z; Giralt S; De Lima M; Hosing C; Kharfan-Dabaja M A; Anagnostopoulos A; Champlin R
Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
Bone marrow transplantation 2002;30(8):543-6.
2002: Giralt S; Aleman A; Anagnostopoulos A; Weber D; Khouri I; Anderlini P; Molldrem J; Ueno N T; Donato M; Korbling M; Gajewski J; Alexanian R; Champlin R
Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.
Bone marrow transplantation 2002;30(6):367-73.
2002: Kantarjian Hagop M; O'Brien Susan; Cortes Jorge E; Giralt Sergio A; Rios Mary Beth; Shan Jianqin; Giles Francis J; Thomas Deborah A; Faderl Stefan; De Lima Marcos; Garcia-Manero Guillermo; Champlin Richard; Arlinghaus Ralph; Talpaz Moshe
Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia.
Blood 2002;100(5):1590-5.
2002: Konopleva Marina; Zhao Shourong; Hu Wei; Jiang Shuwei; Snell Virginia; Weidner Douglas; Jackson C Ellen; Zhang Xin; Champlin Richard; Estey Elihu; Reed John C; Andreeff Michael
The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells.
British journal of haematology 2002;118(2):521-34.
2002: Giralt Sergio; Anagnostopoulos Athanasios; Shahjahan Munir; Champlin Richard;
Nonablative stem cell transplantation for older patients with acute leukemias and myelodysplastic syndromes.
Seminars in hematology 2002;39(1):57-62.
2002: Gajewski James L; Rondon Gabriela; Donato Michele L; Anderlini Paolo; Korbling Martin; Ippoliti Cindy; Benyunes Mark; Miller Langdon L; LaTemple Denise; Jones Denny; Ashby Mark; Hellmann Sue; Durett April; Lauppe Jo; Geisler Deborah; Khouri Issa F; Giralt Sergio A; Andersson Borje; Ueno Naoto T; Champlin Richard
Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(10):550-6.
2002: Khouri Issa; Giralt Sergio; Champlin Richard
Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy.
Cancer treatment and research 2002;110():137-47.
2001: Przepiorka D; Anderlini P; Saliba R; Cleary K; Mehra R; Khouri I; Huh Y O; Giralt S; Braunschweig I; van Besien K; Champlin R
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation.
Blood 2001;98(6):1695-700.
2001: Bibawi S; Abi-Said D; Fayad L; Anderlini P; Ueno N T; Mehra R; Khouri I; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Andreeff M; Andersson B S; Estey E H; Champlin R; Przepiorka D
Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
American journal of hematology 2001;67(4):227-33.
2001: Ravandi F; Kantarjian H; Cohen A; Davis M; O'Brien S; Anderlini P; Andersson B; Claxton D; Donato M; Gajewski J; Khouri I; Korbling M; Ueno N; deVos D; Champlin R; Giralt S
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study.
Bone marrow transplantation 2001;27(12):1221-5.
2001: Przepiorka D; Smith T L; Folloder J; Anderlini P; Chan K W; Körbling M; Lichtiger B; Norfleet F; Champlin R
Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors.
Blood 2001;97(11):3405-10.
2001: Alexanian R; Weber D; Giralt S; Dimopoulos M; Delasalle K; Smith T; Champlin R
Impact of complete remission with intensive therapy in patients with responsive multiple myeloma.
Bone marrow transplantation 2001;27(10):1037-43.
2001: Anagnostopoulos A; Dimopoulos M A; Aleman A; Weber D; Alexanian R; Champlin R; Giralt S
High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia.
Bone marrow transplantation 2001;27(10):1027-9.
2001: Champlin R; Khouri I; Anderlini P; Gajewski J; Kornblau S; Molldrem J; Shimoni A; Ueno N; Giralt S
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation.
Bone marrow transplantation 2001;27 Suppl 2():S13-22.
2001: Shimoni A; Smith T L; Aleman A; Weber D; Dimopoulos M; Anderlini P; Andersson B; Claxton D; Ueno N T; Khouri I; Donato M; Korbling M; Alexanian R; Champlin R; Giralt S
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma.
Bone marrow transplantation 2001;27(8):821-8.
2001: Kornblau S M; Stiouf I; Snell V; Przepiorka D; Stephens L C; Champlin R; Marini F C
Preemptive control of graft-versus-host disease in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.
Cancer research 2001;61(8):3355-60.
2001: Giralt S; Thall P F; Khouri I; Wang X; Braunschweig I; Ippolitti C; Claxton D; Donato M; Bruton J; Cohen A; Davis M; Andersson B S; Anderlini P; Gajewski J; Kornblau S; Andreeff M; Przepiorka D; Ueno N T; Molldrem J; Champlin R
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.
Blood 2001;97(3):631-7.
2001: Wang Y; Liu J; Wu Y; Luo W; Lin S H; Lin H; Hawk N; Sun T; Guo J Q; Estrov Z; Talpaz M; Champlin R; Arlinghaus R B
Expression of a truncated first exon BCR sequence in chronic myelogenous leukemia cells blocks cell growth and induces cell death.
Cancer research 2001;61(1):138-44.
2001: Shimoni A; Gajewski J A; Donato M; Martin T; O'Brien S; Talpaz M; Cohen A; Korbling M; Champlin R; Giralt S
Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(10):568-75.
2001: Körbling M; Giralt S; Khouri I; Mirza N; Donato M; Anderlini P; Fischer H; Andreeff M; McMannis J; Champlin R
Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis.
Journal of clinical apheresis 2001;16(2):82-7.
2000: Shimoni A; Körbling M; Champlin R; Molldrem J
Cryofibrinogenemia and skin necrosis in a patient with diffuse large cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.
Bone marrow transplantation 2000;26(12):1343-5.
2000: Champlin R; Khouri I; Shimoni A; Gajewski J; Kornblau S; Molldrem J; Ueno N; Giralt S; Anderlini P
Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.
British journal of haematology 2000;111(1):18-29.
2000: de Lima M; van Besien K; Gajewski J; Khouri I; Andersson B; Korbling M; Champlin R; Giralt S
High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant.
Bone marrow transplantation 2000;26(3):333-8.
2000: Abbott B; Ippoliti C; Hecth D; Bruton J; Whaley B; Champlin R
Granisetron (Kytril) plus dexamethasone for antiemetic control in bone marrow transplant patients receiving highly emetogenic chemotherapy with or without total body irradiation.
Bone marrow transplantation 2000;25(12):1279-83.
2000: Champlin R; van Besien K; Giralt S; Khouri I
Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens.
Current oncology reports 2000;2(2):182-91.
2000: Shimoni A; Giralt S; Khouri I; Champlin R
Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect.
Current oncology reports 2000;2(2):132-9.
2000: Hanna H; Raad I; Gonzalez V; Umphrey J; Tarrand J; Neumann J; Champlin R
Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2000;21(3):226-8.
2000: Przepiorka D; Kernan N A; Ippoliti C; Papadopoulos E B; Giralt S; Khouri I; Lu J G; Gajewski J; Durett A; Cleary K; Champlin R; Andersson B S; Light S
Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease.
Blood 2000;95(1):83-9.
2000: Braunschweig I; Mirza N Q; Rondon G; Lauppe J; Mehra R; Gajewski J; Körbling M; Huh Y O; Geisler D; Gee A P; Champlin R; Przepiorka D
High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer.
Cytotherapy 2000;2(2):105-10.
2000: Donato M; Champlin R
Granulocyte colony-stimulating factor--primed allogeneic bone marrow transplants: capturing the advantages of blood stem cell transplants without increased risk of chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(4A):419-21.
2000: Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri I F; Folloder J; Ueno N T; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson B S; Champlin R
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(2A):190-7.
2000: Nash R A; Kurzrock R; DiPersio J; Vose J; Linker C; Maharaj D; Nademanee A P; Negrin R; Nimer S; Shulman H; Ashby M; Jones D; Appelbaum F R; Champlin R
A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(1):25-34.
1999: Khouri I F; Lee M S; Romaguera J; Mirza N; Kantarjian H; Korbling M; Albitar M; Giralt S; Samuels B; Anderlini P; Rodriguez J; von Wolff B; Gajewski J; Cabanillas F; Champlin R
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1293-9.
1999: Champlin R; Khouri I; Kornblau S; Marini F; Anderlini P; Ueno N T; Molldrem J; Giralt S
Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy.
Hematology/oncology clinics of North America 1999;13(5):1041-57, vii-viii.
1999: Przepiorka D; Khouri I; Ippoliti C; Ueno N T; Mehra R; Körbling M; Giralt S; Gajewski J; Fischer H; Donato M; Cleary K; Claxton D; Chan K W; Braunschweig I; van Besien K; Andersson B S; Anderlini P; Champlin R
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.
Bone marrow transplantation 1999;24(7):763-8.
1999: Ghosh S; Champlin R; Couch R; Englund J; Raad I; Malik S; Luna M; Whimbey E
Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(3):528-32.
1999: Maltezou H; Whimbey E; Abi-Said D; Przepiorka D; Champlin R; Goodrich J;
Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study.
Bone marrow transplantation 1999;24(6):665-9.
1999: Przepiorka D; Smith T L; Folloder J; Khouri I; Ueno N T; Mehra R; Körbling M; Huh Y O; Giralt S; Gajewski J; Donato M; Cleary K; Claxton D; Braunschweig I; van Besien K; Andersson B S; Anderlini P; Champlin R
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.
Blood 1999;94(4):1465-70.
1999: Anderlini P; Riggs S A; Körbling M; Champlin R
Syngeneic blood stem cell transplantation for infectious mononucleosis-related aplastic anaemia.
British journal of haematology 1999;106(1):159-61.
1999: Warkentin D; Ippoliti C; Bruton J; Van Besien K; Champlin R
Toxicity of single daily dose gentamicin in stem cell transplantation.
Bone marrow transplantation 1999;24(1):57-61.
1999: Marini F C; Snell V; Yu Q; Zhang X; Singletary S E; Champlin R; Andreeff M
Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1557-68.
1999: Przepiorka D; van Besien K; Khouri I; Hagemeister F; Samuels B; Folloder J; Ueno N T; Molldrem J; Mehra R; Körbling M; Giralt S; Gajewski J; Donato M; Cleary K; Claxton D; Braunschweig I; Andersson B; Anderlini P; Champlin R
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):527-32.
1999: Przepiorka D; Khouri I; Thall P; Mehra R; Lee M S; Ippoliti C; Giralt S; Gajewski J; van Besien K; Andersson B; Körbling M; Deisseroth A B; Champlin R
Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.
Bone marrow transplantation 1999;23(10):977-81.
1999: Champlin R; Khouri I; Komblau S; Molidrem J; Giralt S
Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect.
Oncology (Williston Park, N.Y.) 1999;13(5):621-8; discussion 631, 635-8, 641.
1999: Nguyen Q; Champlin R; Giralt S; Rolston K; Raad I; Jacobson K; Ippoliti C; Hecht D; Tarrand J; Luna M; Whimbey E
Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(3):618-23.
1999: Champlin R; Khouri I; Kornblau S; Molldrem J; Giralt S
Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy.
Current opinion in oncology 1999;11(2):87-95.
1999: Abbott B; Ippoliti C; Bruton J; Neumann J; Whaley R; Champlin R
Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
Bone marrow transplantation 1999;23(3):265-9.
1999: Bachier C R; Giles R E; Ellerson D; Hanania E G; Garcia-Sanchez F; Andreeff M; Cabanillas F; Champlin R; Choudhury R; Berenson R; Heimfeld S; Deisseroth A B
Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;32(3-4):279-88.
1999: Przepiorka D; Lu J G; Anderlini P; Körbling M; Donato M; Champlin R; Gee A P; van Vlasselaer P
Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel system.
Cytotherapy 1999;1(2):111-7.
1999: Giralt S; Khouri I; Champlin R
Non myeloablative "mini transplants".
Cancer treatment and research 1999;101():97-108.
1999: Champlin R; Khouri I; Giralt S
Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modality.
Pediatric transplantation 1999;3 Suppl 1():52-8.
1999: Champlin R; Khouri I; Giralt S
Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: induction of graft-vs.-malignancy as treatment for malignant diseases.
Journal of clinical apheresis 1999;14(1):45-9.
1998: Khouri I F; Romaguera J; Kantarjian H; Palmer J L; Pugh W C; Korbling M; Hagemeister F; Samuels B; Rodriguez A; Giralt S; Younes A; Przepiorka D; Claxton D; Cabanillas F; Champlin R
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3803-9.
1998: Rahman Z; Kavanagh J; Champlin R; Giles R; Hanania E; Fu S; Zu Z; Mehra R; Holmes F; Kudelka A; Claxton D; Verschraegen C; Gajewski J; Andreeff M; Heimfeld S; Berenson R; Ellerson D; Calvert L; Mechetner E; Holzmayer T; Dayne A; Hamer J; Bachier C; Ostrove J; Deisseroth A
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(11):2717-21.
1998: Khouri I F; Keating M J; Champlin R
Hematopoietic stem cell transplantation for chronic lymphocytic leukemia.
Current opinion in hematology 1998;5(6):454-9.
1998: Narvios A B; Przepiorka D; Tarrand J; Chan K W; Champlin R; Lichtiger B
Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
Bone marrow transplantation 1998;22(6):575-7.
1998: Khouri I F; Keating M; Körbling M; Przepiorka D; Anderlini P; O'Brien S; Giralt S; Ippoliti C; von Wolff B; Gajewski J; Donato M; Claxton D; Ueno N; Andersson B; Gee A; Champlin R
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2817-24.
1998: Anderlini P; Przepiorka D; Körbling M; Champlin R
Blood stem cell procurement: donor safety issues.
Bone marrow transplantation 1998;21 Suppl 3():S35-9.
1998: Bernstein S H; Nademanee A P; Vose J M; Tricot G; Fay J W; Negrin R S; DiPersio J; Rondon G; Champlin R; Barnett M J; Cornetta K; Herzig G P; Vaughan W; Geils G; Keating A; Messner H; Wolff S N; Miller K B; Linker C; Cairo M; Hellmann S; Ashby M; Stryker S; Nash R A
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation.
Blood 1998;91(9):3509-17.
1998: Seong C; Delasalle K; Hayes K; Weber D; Dimopoulos M; Swantkowski J; Huh Y; Glassman A; Champlin R; Alexanian R
Prognostic value of cytogenetics in multiple myeloma.
British journal of haematology 1998;101(1):189-94.
1998: Popat U; Przepiork D; Champlin R; Pugh W; Amin K; Mehra R; Rodriguez J; Giralt S; Romaguera J; Rodriguez A; Preti A; Andersson B; Khouri I; Claxton D; de Lima M; Donato M; Anderlini P; Gajewski J; Cabanillas F; van Besien K
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):63-9.
1998: Przepiorka D; Giralt S; Khouri I; Champlin R; Bueso-Ramos C
Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases.
American journal of hematology 1998;57(1):24-8.
1998: Jones D V; Ashby M; Vadhan-Raj S; Somlo G; Champlin R; Gajewski J; Hellmann S; Fyfe G
Recombinant human thrombopoietin clinical development.
Stem cells (Dayton, Ohio) 1998;16 Suppl 2():199-206.
1998: Shpall E J; Champlin R; Glaspy J A
Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(2):84-92.
1997: Shpall E J; LeMaistre C F; Holland K; Ball E; Jones R B; Saral R; Jacobs C; Heimfeld S; Berenson R; Champlin R
A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy.
Blood 1997;90(11):4313-20.
1997: Ippoliti C; Champlin R; Bugazia N; Przepiorka D; Neumann J; Giralt S; Khouri I; Gajewski J
Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3350-4.
1997: Rahman Z; Champlin R; Rondon G; Frye D; Valero V; Mehra R; Hortobagyi G
Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-77-S17-80.
1997: Ippoliti C; Morgan A; Warkentin D; van Besien K; Mehra R; Khouri I; Giralt S; Gajewski J; Champlin R; Andersson B; Przepiorka D
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
Bone marrow transplantation 1997;20(6):491-5.
1997: van Besien K; Thall P; Korbling M; Pugh W C; Khouri I; Mehra R; Giralt S; Anderlini P; Amin K; Mirza N; Seong D; Gajewski J; Hester J; Andersson B; Cabanillas F; Champlin R; Przepiorka D
Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(3):150-6.
1997: Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan K W; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(2):76-82.
1997: van Besien K; Forman A; Champlin R
Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(6):515-24.
1997: Giralt S; Estey E; Albitar M; van Besien K; Rondón G; Anderlini P; O'Brien S; Khouri I; Gajewski J; Mehra R; Claxton D; Andersson B; Beran M; Przepiorka D; Koller C; Kornblau S; Kørbling M; Keating M; Kantarjian H; Champlin R
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
Blood 1997;89(12):4531-6.
1997: Garcia R; Raad I; Abi-Said D; Bodey G; Champlin R; Tarrand J; Hill L A; Umphrey J; Neumann J; Englund J; Whimbey E
Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1997;18(6):412-6.
1997: Rondón G; Giralt S; Pereira M; Van Besien K; Mehra R; Champlin R; Andreeff M
Analysis of chimerism following allogeneic bone marrow transplantation by fluorescent-in-situ hybridization.
Leukemia & lymphoma 1997;25(5-6):463-7.
1997: Anderlini P; Przepiorka D; Lauppe J; Seong D; Giralt S; Champlin R; Körbling M
Collection of peripheral blood stem cells from normal donors 60 years of age or older.
British journal of haematology 1997;97(2):485-7.
1997: van Besien K; Verschraegen C; Mehra R; Giralt S; Kudelka A P; Edwards C L; Piamsonboom S; Termrungruanglert W; Champlin R; Kavanagh J J
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue.
Gynecologic oncology 1997;65(2):366-9.
1997: Anderlini P; Przepiorka D; Seong C; Smith T L; Huh Y O; Lauppe J; Champlin R; Körbling M
Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim.
Transfusion 1997;37(5):507-12.
1997: Woo M H; Ippoliti C; Bruton J; Mehra R; Champlin R; Przepiorka D
Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion.
Bone marrow transplantation 1997;19(8):845-7.
1997: Seong C; Durett A; Mirza N; Huh Y; Anderlini P; Champlin R
Mobilization kinetics of CD34+/Thy-1dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors.
Transfusion 1997;37(4):406-10.
1997: Giralt S; Davis M; O'Brien S; van Besien K; Champlin R; de Vos D; Kantarjian H
Studies of decitabine with allogeneic progenitor cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11 Suppl 1():S32-4.
1997: Seong D; Giralt S; Fischer H; Hayes K; Glassman A; Arlinghaus R; Xu J; Kantarjian H; Siciliano M; Champlin R
Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia.
Bone marrow transplantation 1997;19(6):565-70.
1997: Przepiorka D; Anderlini P; Ippoliti C; Khouri I; Fietz T; Thall P; Mehra R; Giralt S; Gajewski J; Deisseroth A B; Cleary K; Champlin R; van Besien K; Andersson B; Körbling M
Allogeneic blood stem cell transplantation in advanced hematologic cancers.
Bone marrow transplantation 1997;19(5):455-60.
1997: Hortobagyi G N; Holmes F A; Ibrahim N; Champlin R; Buzdar A U
The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer.
Seminars in oncology 1997;24(1 Suppl 3):S30-3.
1997: Giralt S; Weber D; Colome M; Dimopoulos M; Mehra R; Van Besien K; Gajewski J; Andersson B; Khouri I; Przepiorka D; von Wolff B; Delasalle K; Korbling M; Seong D; Alexanian R; Champlin R
Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):667-73.
1997: Collins R H; Shpilberg O; Drobyski W R; Porter D L; Giralt S; Champlin R; Goodman S A; Wolff S N; Hu W; Verfaillie C; List A; Dalton W; Ognoskie N; Chetrit A; Antin J H; Nemunaitis J
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):433-44.
1997: Anderlini P; Lauppe J; Przepiorka D; Seong D; Champlin R; Körbling M
Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections.
British journal of haematology 1997;96(2):415-7.
1997: Nicholson V A; Whimbey E; Champlin R; Abi-Said D; Przepiorka D; Tarrand J; Chan K; Bodey G P; Goodrich J M
Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis.
Bone marrow transplantation 1997;19(1):37-41.
1997: Piamsomboon S; Kudelka A P; Termrungruanglert W; Van Besien K; Edwards C L; Lifshitz S; Schomer D F; Champlin R; Mante R P; Kavanagh J J; Verschraegen C F
Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature.
European journal of gynaecological oncology 1997;18(6):453-6.
1997: Kim S W; Rice L; Champlin R; Udden M M
Aplastic anemia in eosinophilic fasciitis: responses to immunosuppression and marrow transplantation.
Haematologia 1997;28(3):131-7.
1996: Przepiorka D; Ippoliti C; Khouri I; Anderlini P; Mehra R; Giralt S; Gajewski J; Fritsche H; Deisseroth A B; Cleary K; Champlin R; van Besien K; Andersson B; Korbling M
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.
Transplantation 1996;62(12):1806-10.
1996: Körbling M; Anderlini P; Durett A; Maadani F; Bojko P; Seong D; Giralt S; Khouri I; Andersson B; Mehra R; vanBesien K; Mirza N; Przepiorka D; Champlin R
Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.
Bone marrow transplantation 1996;18(6):1073-9.
1996: Przepiorka D; Ippoliti C; Khouri I; Woo M; Mehra R; Le Bherz D; Giralt S; Gajewski J; Fischer H; Fritsche H; Deisseroth A B; Cleary K; Champlin R; Besien K; Andersson B; Maher R; Fitzsimmons W
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.
Blood 1996;88(11):4383-9.
1996: Körbling M; Chan K W; Anderlini P; Seong D; Durett A; Langlinais A; Przepiorka D; Gajewski J; Miller P; Sundberg J; Alilaen P; Bojko P; Mirza N; Claxton D; van Besien K; Khouri I; Andersson B; Mehra R; Champlin R
Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors.
Bone marrow transplantation 1996;18(5):885-90.
1996: Lewis V A; Champlin R; Englund J; Couch R; Goodrich J M; Rolston K; Przepiorka D; Mirza N Q; Yousuf H M; Luna M; Bodey G P; Whimbey E
Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(5):1033-7.
1996: van Besien K; Przepiorka D; Mehra R; Giralt S; Khouri I; Gajewski J; Andersson B; Champlin R
Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):3036-42.
1996: Przepiorka D; Van Vlasselaer P; Huynh L; Durett A; Agbor P; Lauppe J; Valone F; Champlin R; Körbling M
Rapid debulking and CD34 enrichment of filgrastim-mobilized peripheral blood stem cells by semiautomated density gradient centrifugation in a closed system.
Journal of hematotherapy 1996;5(5):497-502.
1996: Anderlini P; Przepiorka D; Champlin R; Körbling M
Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals.
Blood 1996;88(8):2819-25.
1996: Champlin R
Purging: the separation of normal from malignant cells for autologous transplantation.
Transfusion 1996;36(10):910-8.
1996: Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R
Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
Bone marrow transplantation 1996;18(3):669-72.
1996: Seong D; Bruner J M; Lee K H; Mirza N; Kwon B D; Lee J H; Lee Y Y; Ro J; Talpaz M; Champlin R; Deisseroth A B
Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(2):402-3.
1996: Anderlini P; Przepiorka D; Seong D; Champlin R; Körbling M
Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis.
British journal of haematology 1996;94(1):155-8.
1996: Anderlini P; Przepiorka D; Seong D; Miller P; Sundberg J; Lichtiger B; Norfleet F; Chan K W; Champlin R; Körbling M
Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures.
Transfusion 1996;36(7):590-5.
1996: Anderlini P; Przepiorka D; Huh Y; Lauppe J; Miller P; Sundberg J; Seong D; Champlin R; Körbling M
Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation.
British journal of haematology 1996;93(4):940-2.
1996: Chan K W; Gajewski J L; Supkis D; Pentz R; Champlin R; Bleyer W A
Use of minors as bone marrow donors: current attitude and management. A survey of 56 pediatric transplantation centers.
The Journal of pediatrics 1996;128(5 Pt 1):644-8.
1996: Körbling M; Champlin R
Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts.
Stem cells (Dayton, Ohio) 1996;14(2):185-95.
1996: Gajewski J; Champlin R
Bone marrow transplantation from unrelated donors.
Current opinion in oncology 1996;8(2):84-8.
1996: Champlin R
Purging: elimination of malignant cells from autologous blood or marrow transplants.
Current opinion in oncology 1996;8(2):79-83.
1996: van Besien K W; Mehra R C; Giralt S A; Kantarjian H M; Pugh W C; Khouri I F; Moon Y; Williams P; Andersson B S; Przepiorka D; McCarthy P L; Gajewski J L; Deisseroth A B; Cabanillas F F; Champlin R
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
The American journal of medicine 1996;100(3):299-307.
1996: Deisseroth A B; Holmes F; Hortobagyi G; Champlin R
Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial.
Human gene therapy 1996;7(3):401-16.
1996: Champlin R; Giralt S; Gajewski J
T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation.
Acta haematologica 1996;95(3-4):157-63.
1995: Giralt S; Hester J; Huh Y; Hirsch-Ginsberg C; Rondón G; Seong D; Lee M; Gajewski J; Van Besien K; Khouri I; Mehra R; Przepiorka D; Körbling M; Talpaz M; Kantarjian H; Fischer H; Deisseroth A; Champlin R
CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Blood 1995;86(11):4337-43.
1995: Hanania E G; Kavanagh J; Hortobagyi G; Giles R E; Champlin R; Deisseroth A B
Recent advances in the application of gene therapy to human disease.
The American journal of medicine 1995;99(5):537-52.
1995: Alexanian R; Dimopoulos M A; Delasalle K B; Hester J; Champlin R
Myeloablative therapy for primary resistant multiple myeloma.
Stem cells (Dayton, Ohio) 1995;13 Suppl 2():118-21.
1995: van Besien K; Demuynck H; Lemaistre C F; Bogaerts M A; Champlin R
High-dose melphalan allows durable engraftment of allogeneic bone marrow.
Bone marrow transplantation 1995;15(2):321-3.
1995: Shaffer L; Giralt S; Champlin R; Chan K W
Treatment of leukemia relapse after bone marrow transplantation with interferon-alpha and interleukin 2.
Bone marrow transplantation 1995;15(2):317-9.
1995: Champlin R
Optimizing the composition of bone marrow for allogenic transplantation.
Journal of hematotherapy 1995;4(1):53-60.
1994: Alexanian R; Dimopoulos M A; Hester J; Delasalle K; Champlin R
Early myeloablative therapy for multiple myeloma.
Blood 1994;84(12):4278-82.
1994: Deisseroth A B; Kavanagh J; Champlin R
Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial.
Human gene therapy 1994;5(12):1507-22.
1994: Schiller G; Gajewski J; Lee M; Ho W; Territo M; Champlin R
Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.
Leukemia & lymphoma 1994;15(1-2):85-90.
1994: Schiller G; Feig S A; Territo M; Wolin M; Lill M; Belin T; Hunt L; Nimer S; Champlin R; Gajewski J
Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors.
British journal of haematology 1994;88(1):72-8.
1994: Dimopoulos M A; Hester J; Huh Y; Champlin R; Alexanian R
Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma.
British journal of haematology 1994;87(4):730-4.
1994: Kantarjian H M; Talpaz M; Andersson B; Khouri I; Giralt S; Rios M B; Champlin R; Hester J; Deisseroth A B
High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia.
Bone marrow transplantation 1994;14(1):57-61.
1994: Dimopoulos M A; Weber D M; Hester J; Delasalle K; Champlin R; Alexanian R
Intensive sequential therapy for VAD-resistant multiple myeloma.
Leukemia & lymphoma 1994;13(5-6):479-84.
1994: Alexanian R; Dimopoulos M; Smith T; Delasalle K; Barlogie B; Champlin R
Limited value of myeloablative therapy for late multiple myeloma.
Blood 1994;83(2):512-6.
1993: Deisseroth A B; Kantarjian H; Talpaz M; Champlin R; Reading C; Hanania E G; Fu S; Randhawa G S; Cha Y; Fang X
Molecular approaches to the diagnosis and treatment of cancer.
Stem cells (Dayton, Ohio) 1993;11 Suppl 3():129-30.
1993: Schiller G; Nimer S; Gajewski J; Lee M; Ho W; Territo M; Champlin R
Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study.
Leukemia & lymphoma 1993;11(1-2):69-77.
1993: Champlin R
Allogeneic, syngeneic and autologous bone marrow transplantation for chronic myelogenous leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(7):1084-6.
1993: Deisseroth A B; Kantarjian H; Talpaz M; Champlin R; Reading C; Andersson B; Claxton D
Use of two retroviral markers to test relative contribution of marrow and peripheral blood autologous cells to recovery after preparative therapy. The University of Texas M.D. Anderson Cancer Center. Division of Medicine.
Human gene therapy 1993;4(1):71-85.
1993: Dimopoulos M A; Delasalle K B; Champlin R; Alexanian R
Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma.
British journal of haematology 1993;83(2):240-4.
1993: Seong D C; Liu P; Siciliano J; Zhao Y; Cork A; Henske E; Warburton D; Yu M T; Champlin R; Trujillo J M
Detection of variant Ph-positive chronic myelogenous leukemia involving chromosomes 1, 9, and 22 by fluorescence in situ hybridization.
Cancer genetics and cytogenetics 1993;65(2):100-3.
1993: Champlin R
Bone marrow transplantation for Hodgkin's disease--recent advances and current issues.
Leukemia & lymphoma 1993;10 Suppl():103-8.
1993: Champlin R
Bone marrow transplantation for leukemia utilizing HLA-matched unrelated donors.
Bone marrow transplantation 1993;11 Suppl 1():74-7.
1993: Champlin R; Coppo P; Howe C
National Marrow Donor Program: progress and challenges.
Bone marrow transplantation 1993;11 Suppl 1():41-4.
1993: Champlin R
Allogeneic bone marrow transplantation using unrelated donors.
Leukemia & lymphoma 1993;11 Suppl 2():149-52.
1993: Deisseroth A B; Hanania E G; Fu S; Claxton D; Andreeff M; Champlin R; Kavanagh J; Hortobagyi G; Holmes F; Reading C
Genetic therapy of human neoplastic disease.
Journal of hematotherapy 1993;2(3):373-5.
1993: Champlin R
Bone marrow transplantation from HLA-matched unrelated donors as treatment for leukemia.
Journal of hematotherapy 1993;2(3):323-7.
1993: Champlin R
T-cell depletion for allogeneic bone marrow transplantation: impact on graft-versus-host disease, engraftment, and graft-versus-leukemia.
Journal of hematotherapy 1993;2(1):27-42.
1992: Lee M; Khouri I; Champlin R; Kantarjian H; Talpaz M; Trujillo J; Freireich E; Deisseroth A; Stass S
Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation.
British journal of haematology 1992;82(4):708-14.
1992: Schiller G; Gajewski J; Territo M; Nimer S; Lee M; Belin T; Champlin R
Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.
Blood 1992;80(12):2977-82.
1992: Champlin R
Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
Seminars in hematology 1992;29(3 Suppl 2):46-52.
1992: Schiller G; Gajewski J; Nimer S; Territo M; Ho W; Lee M; Champlin R
A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia.
British journal of haematology 1992;81(2):170-7.
1992: Champlin R; Giralt S; Przepiorka D; Ho W; Lee K; Gajewski J; Nimer S; Andersson B; Wallerstein R; Ippolito C
Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.
Progress in clinical and biological research 1992;377():385-94; discussion 395-8.
1991: Champlin R
Immunobiology of bone marrow transplantation as treatment for hematologic malignancies.
Transplantation proceedings 1991;23(4):2123-7.
1991: Kato Y; Mitsuishi Y; Cecka M; Hopfield J; Hunt L; Champlin R; Terasaki P I; Gajewski J L
HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplants.
Transplantation 1991;52(2):374-6.
1991: Nimer S D; Golde D W; Kwan K; Lee K; Clark S; Champlin R
In vitro production of granulocyte-macrophage colony-stimulating factor in aplastic anemia: possible mechanisms of action of antithymocyte globulin.
Blood 1991;78(1):163-8.
1991: Champlin R; Jansen J; Ho W; Gajewski J; Nimer S; Lee K; Territo M; Winston D; Tricot G; Reichert T
Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.
Transplantation proceedings 1991;23(1 Pt 2):1695-6.
1990: Faisal M; Cumberland W; Champlin R; Fahey J L
Effect of recombinant human granulocyte-macrophage colony-stimulating factor administration on the lymphocyte subsets of patients with refractory aplastic anemia.
Blood 1990;76(8):1580-5.
1990: Sun G X; Sparkes R S; Wormsley S; Naeim F; Champlin R; Gale R P
Are some cases of acute leukemia with t(8;21) hybrid leukemias?
Cancer genetics and cytogenetics 1990;49(2):177-84.
1990: Champlin R; Ho W; Gajewski J; Feig S; Burnison M; Holley G; Greenberg P; Lee K; Schmid I; Giorgi J
Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
Blood 1990;76(2):418-23.
1990: Champlin R; Gajewski J; Nimer S; Vollset S; Landaw E; Winston D; Schiller G; Ho W
Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1199-206.
1990: Gajewski J; Cecka M; Champlin R
Bone marrow transplantation utilizing HLA-matched unrelated marrow donors.
Blood reviews 1990;4(2):132-8.
1990: Champlin R
T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation.
Hematology/oncology clinics of North America 1990;4(3):687-98.
1990: Champlin R
Bone marrow transplantation for chronic myelogenous leukemia.
Current opinion in oncology 1990;2(2):258-62.
1990: Sawyers C L; Timson L; Kawasaki E S; Clark S S; Witte O N; Champlin R
Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(2):563-7.
1990: Naeim F; Champlin R; Nimer S
Bone marrow changes in patients with refractory aplastic anemia treated by recombinant GM-CSF.
Hematologic pathology 1990;4(2):79-85.
1989: Champlin R; Gale R P
Acute lymphoblastic leukemia: recent advances in biology and therapy.
Blood 1989;73(8):2051-66.
1989: Champlin R; Gajewski J; Feig S; Giorgi J; Lyddane N; Lee K; Schmidt I; Winston D; Ho W; Reichert T
Selective depletion of CD8 positive T-lymphocytes for prevention of graft-versus-host disease following allogeneic bone marrow transplantation.
Transplantation proceedings 1989;21(1 Pt 3):2947-8.
1988: Kawasaki E S; Clark S S; Coyne M Y; Smith S D; Champlin R; Witte O N; McCormick F P
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(15):5698-702.
1988: Champlin R
Treatment for victims of nuclear accidents: the role of bone marrow transplantation.
Radiation research 1988;113(2):205-10.
1987: Champlin R
The role of bone marrow transplantation for nuclear accidents: implications of the Chernobyl disaster.
Seminars in hematology 1987;24(3 Suppl 2):1-4.
1987: Champlin R; Ho W; Winston D; Decker R; Greenberg P; Burnison M; Holly F E; Gale R P
Treatment of adults with acute myelogenous leukemia: prospective evaluation of high-dose cytarabine in consolidation chemotherapy and with bone marrow transplantation.
Seminars in oncology 1987;14(2 Suppl 1):1-6.
1987: Champlin R
Bone marrow transplantation for leukemia: effects of T lymphocyte depletion of donor bone marrow.
Transplantation proceedings 1987;19(1 Pt 1):157-9.
1987: Champlin R; Gale R P
Bone marrow transplantation: its biology and role as treatment for acute and chronic leukemias.
Annals of the New York Academy of Sciences 1987;511():447-58.
1985: Champlin R; Jacobs A; Gale R P; Ho W; Selch M; Lenarsky C; Feig S A
High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results.
Seminars in oncology 1985;12(2 Suppl 3):190-5.
1984: Bayever E; Champlin R; Ho W; Lenarsky C; Storch S; Ladisch S; Gale R P; Feig S A
Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia.
The Journal of pediatrics 1984;105(6):920-5.
1984: Champlin R; Ho W; Bayever E; Winston D J; Lenarsky C; Feig S A; Gale R P
Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody.
Progress in clinical and biological research 1984;148():227-38.
1983: Feig S A; Champlin R; Arenson E; Yale C; Ho W; Tesler A; Gale R P
Improved survival following bone marrow transplantation for aplastic anaemia.
British journal of haematology 1983;54(4):509-17.
1982: Champlin R; Ho W; Arenson E; Gale R P
Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase.
Blood 1982;60(4):1038-41.
1981: Gale R P; Ho W; Feig S; Champlin R; Tesler A; Arenson E; Ladish S; Young L; Winston D; Sparkes R; Fitchen J; Territo M; Sarna G; Wong L; Paik Y; Bryson Y; Golde D; Fahey J; Cline M
Prevention of graft rejection following bone marrow transplantation.
Blood 1981;57(1):9-12.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Richard Champlin

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Phenomena

Chemicals & Drugs

Anatomy

Living Beings

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Richard Champlin (preview)

All Publications